Antidepressants in states of cognitive dysfunction
暂无分享,去创建一个
[1] M. Fisman. Pseudodementia , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[2] H. Wittchen,et al. Depressive neurosis , 1985, Acta psychiatrica Scandinavica.
[3] D. Murphy,et al. Self-stimulation responses are altered following long-term but not short-term treatment with clorgyline , 1983, Brain Research.
[4] I. Shoulson,et al. Psychiatric syndromes in Huntington's disease. , 1983, The American journal of psychiatry.
[5] L. Chiodo,et al. Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells , 1983, Brain Research.
[6] D. Murphy,et al. Chronic effects of a monoamine oxidase-inhibiting antidepressant: decreases in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3': 5'- monophosphate systems in rat brain , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] L. Major,et al. Abnormal dexamethasone suppression test results in chronic schizophrenic patients. , 1982, The American journal of psychiatry.
[8] P. Madeley,et al. A controlled study of dementia in Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[9] A. Stoll,et al. Mood, vegetative disturbance, and dexamethasone suppression test after stroke , 1982, Annals of neurology.
[10] C. Coffey,et al. Treatment of the “on‐off” phenomenon in parkisnonism with lithium carbonate , 1982, Annals of neurology.
[11] S. Checkley,et al. The Effect of Desipramine upon Central Adrenergic Function in Depressed Patients , 1982, British Journal of Psychiatry.
[12] P. King. Psychopathology in the Aged , 1982 .
[13] D. Murphy,et al. Functional subsensitivity of alpha 2-adrenoceptors accompanies reductions in yohimbine binding after clorgyline treatment. , 1982, European journal of pharmacology.
[14] L. Surányi,et al. Amitriptyline in Alzheimer's disease , 1982, Neurology.
[15] Price Tr,et al. Severe depressive pseudodementia with and without dementia. , 1982 .
[16] D. Murphy,et al. Effort and cognition in depression. , 1982, Archives of general psychiatry.
[17] E. Larson,et al. Coexistence of cognitive impairment and depression in geriatric outpatients. , 1982, The American journal of psychiatry.
[18] F E Bloom,et al. Noradrenergic and serotonergic fibers innervate complementary layers in monkey primary visual cortex: an immunohistochemical study. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Gaspar,et al. ECT in psychogeriatric practice--a study of risk factors, indications and outcome. , 1982, Comprehensive psychiatry.
[20] R. Branconnier,et al. Amitriptyline selectively disrupts verbal recall from secondary memory of the normal aged , 1982, Neurobiology of Aging.
[21] B. Carroll. The Dexamethasone Suppression Test for Melancholia , 1982, British Journal of Psychiatry.
[22] W. Bondareff,et al. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.
[23] R. Gerner,et al. Does the dexamethasone suppression test distinguish dementia from depression? , 1982, The American journal of psychiatry.
[24] E. Caine. Pseudodementia: Current Concepts and Future Directions , 1981 .
[25] A. Phillips,et al. Increased intracranial self-stimulation in rats after long-term administration of desipramine. , 1981, Science.
[26] D. Heal,et al. Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents. , 1981, European journal of pharmacology.
[27] D. Charney,et al. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. , 1981, Archives of general psychiatry.
[28] R. Glass,et al. Cognitive Dysfunction and Imipramine in Outpatient Depressives , 1981 .
[29] R. Cohen,et al. Peptide challenges in affective illness. , 1981, Journal of Clinical Psychopharmacology.
[30] E. Zacny,et al. The effect of single and chronic administration of imipramine on clonidine-induced hypothermia in the rat. , 1981, Life sciences.
[31] R. Katz,et al. Animal models and human depressive disorders , 1981, Neuroscience & Biobehavioral Reviews.
[32] H. Weingartner,et al. Memory failures in progressive idiopathic dementia. , 1981, Journal of abnormal psychology.
[33] R. Robinson,et al. Mood change following left hemispheric brain injury , 1981, Annals of neurology.
[34] D. Murphy,et al. Antidepressants and alpha 2-adrenergic autoreceptor desensitization. , 1981, The American journal of psychiatry.
[35] J. García-Sevilla,et al. α2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment , 1981, Brain Research.
[36] H. Fibiger,et al. Functional evidence for subsensitivity of noradrenergic alpha 2 receptors after chronic desipramine treatment. , 1980, Life sciences.
[37] Feinberg Jf. The Wernicke-Korsakoff syndrome. , 1980 .
[38] D. Murphy,et al. Presnyaptic noradrenergic regulation during depression and antidepressant drug treatment , 1980, Psychiatry Research.
[39] M S Buchsbaum,et al. Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men. , 1980, Archives of general psychiatry.
[40] P. Yates,et al. Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia , 1980, British Journal of Psychiatry.
[41] S. Pradhan. Central neurotransmitters and aging. , 1980, Life sciences.
[42] R. Mair,et al. Memory enhancement in Korsakoff's psychosis by clonidine: Further evidence for a noradrenergic deficit , 1980, Annals of neurology.
[43] J. Coyle,et al. The differential effect of right versus left hemispheric cerebral infarction on catecholamines and behavior in the rat , 1980, Brain Research.
[44] M. Zigmond,et al. Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. , 1980, Science.
[45] D. Overstreet,et al. Receptor alterations and drug tolerance. , 1979, Life sciences.
[46] M. Kupersmith,et al. Dementia in Parkinson disease , 1979, Annals of neurology.
[47] B. Winblad,et al. Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type , 1979, British Journal of Psychiatry.
[48] C. Wells. Manual of Neurologic Therapeutics with Essentials of Diagnosis , 1979 .
[49] J. Morrison,et al. Noradrenergic innervation of cerebral cortex: widespread effects of local cortical lesions. , 1979, Science.
[50] M. Ron,et al. Diagnostic Accuracy in Presenile Dementia , 1979, British Journal of Psychiatry.
[51] T. Usdin,et al. Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. , 1978, Science.
[52] R. Mair,et al. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. , 1978, Science.
[53] R. Wise. Catecholamine theories of reward: A critical review , 1978, Brain Research.
[54] H. Weingartner,et al. Human serial learning: enhancement with arecholine and choline impairment with scopolamine. , 1978, Science.
[55] H. Weingartner,et al. Choline: Selective enhancement of serial learning and encoding of low imagery words in man. , 1978, Life sciences.
[56] D. Shraberg. The myth of pseudodementia: depression and the aging brain. , 1978, The American journal of psychiatry.
[57] R. D. Hunt,et al. Huntington's dementia. Clinical and neuropsychological features. , 1978, Archives of general psychiatry.
[58] J. Vetulani,et al. Mode of action of antidepressant drugs. , 1978, Biochemical pharmacology.
[59] G. Bots,et al. Viral meningoencephalitis and head injury , 1978, Acta neurologica Scandinavica.
[60] M. Folstein,et al. Mood disorder as a specific complication of stroke. , 1977, Journal of neurology, neurosurgery, and psychiatry.
[61] C. Gaitz,et al. Pharmacotherapy for organic brain syndrome in late life. Evaluation of an ergot derivative vs placebo. , 1977, Archives of general psychiatry.
[62] R. Marttila,et al. DEMENTIA IN PARKINSON'S DISEASE , 1976, Acta neurologica Scandinavica.
[63] L. Cermak,et al. A Comparison of the Information Processing Deficits of Patients with Huntington's Chorea and Korsakoff's Syndrome , 1976, Cortex.
[64] M. Jarvik,et al. Memory Functions in Depression: Improvement With Antidepressant Medication , 1976 .
[65] A. H. Kidd,et al. Depression and senility. , 1975, Journal of clinical psychology.
[66] Jenkins Rb,et al. Improvement of Parkinsonism in depressed patients treated with ECT. , 1975 .
[67] W. Miller. Psychological deficit in depression. , 1975, Psychological bulletin.
[68] M. Macfarlane,et al. Procaine (Gerovital H3) Therapy: Mechanism of Inhibition of Monoamine Oxidase , 1974, Journal of the American Geriatrics Society.
[69] S. Potkin,et al. Pharmacology of Depression in the Aged: Evaluation of Gerovital H3 as an Antidepressant Drug , 1974 .
[70] C. Gottfries,et al. Cerebrospinal Fluid pH and Monoamine and Glucolytic Metabolites in Alzheimer's Disease , 1974, British Journal of Psychiatry.
[71] Y. Agid,et al. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.
[72] Y. Naum,et al. Growth of Pulmonary Alveolar Macrophages in vitro , 1973, Nature.
[73] DAVID M. BANEN,et al. An Ergot Preparation (Hydergine) for Relief of Symptoms of Cerebrovascular Insufficiency , 1972, Journal of the American Geriatrics Society.
[74] F. Kelly,et al. AN ERGOT PREPARATION (HYDERGINE) IN THE TREATMENT OF CEREBROVASCULAR DISORDERS IN THE GERIATRIC PATIENT: DOUBLE‐BLIND STUDY , 1971, Journal of the American Geriatrics Society.
[75] S. Arieti. American Handbook of Psychiatry , 1960 .
[76] T. Ban,et al. Pharmacotherapy of the Organic Brain Syndrome in Late Life , 1985 .
[77] E. Richelson. Antimuscarinic and other receptor-blocking properties of antidepressants. , 1983, Mayo Clinic proceedings.
[78] S Davis,et al. Cognitive processes in depression. , 1982, Journal of clinical psychology.
[79] T. Price,et al. Severe depressive pseudodementia with and without dementia. , 1982, The American journal of psychiatry.
[80] H. Klawans. Behavioral Alterations and the Therapy of Parkinsonism , 1982, Clinical neuropharmacology.
[81] R. Thompson,et al. The Molecular basis of neuropathology , 1981 .
[82] C. Wells,et al. Case studies in neuropsychiatry: diagnosis and treatment of coexistent dementia and depression. , 1981, The Journal of clinical psychiatry.
[83] Miller Ne. The measurement of mood in senile brain disease: examiner ratings and self-reports. , 1980 .
[84] N. Miller. The measurement of mood in senile brain disease: examiner ratings and self-reports. , 1980, Proceedings of the annual meeting of the American Psychopathological Association.
[85] U. Rinne. Recent advances in research on Parkinsonism. , 1978, Acta neurologica Scandinavica. Supplementum.
[86] P. Teitelbaum,et al. New Considerations in the Neuropsychology of Motivated Behaviors , 1977 .
[87] L. Pohorecky,et al. Coping Behavior and Neurochemical Changes An Alternative Explanation for the Original "Learned Helplessness" Experiments , 1976 .
[88] L. Pohorecky,et al. Coping Behavior and Neurochemical Changes , 1976 .
[89] J. Davis,et al. Improvement of depression and parkinsonism during ECT: a case study. , 1976, Neuropsychobiology.
[90] S. Soni,et al. Dihydrogenated Alkaloids of Ergotoxine in Non-Hospitalised Elderly Patients , 1975 .
[91] D. Gorelick,et al. The Role of Catecholamines in Animal Learning and Memory , 1975 .
[92] Z. Lebensohn,et al. Improvement of Parkinsonism in depressed patients treated with ECT. , 1975, The American journal of psychiatry.
[93] K. S. Ditman,et al. Gerovital H3 in the treatment of the depressed aging patient. , 1974, Psychosomatics.
[94] S. Gershon,et al. A trial of Gerovital H-3 in depression during senility. , 1974, Current therapeutic research, clinical and experimental.
[95] L. Cermak,et al. The extent of the verbal encoding ability of Korsakoff patients. , 1973, Neuropsychologia.
[96] W. Wanamaker,et al. Psychiatric disturbances in Parkinson's disease. , 1972, Diseases of the nervous system.
[97] John W. Brazer. Catecholamine hypothesis of affective disorders , 1969 .